This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.
Nick Meade is a member of the NIHR Advanced Therapy Medicinal Product (ATMP) Group and Joint Interim Chief Executive and Director of Policy Genetic Alliance UK, the largest alliance of organisations supporting people with genetic, rare and undiagnosed conditions in the UK.
Together with Alice Williams, Nick is leading on engagement activities with patients and the public related to ATMP research. The work they are undertaking aims to enable members of the public and patients to become more aware of, and involved in, ATMP studies.